Publications

by alumni of

University of Southern California → Leonard D. Schaeffer Center for Health Policy and Economics

These are publications listed in RePEc written by alumni of the above institution who are registered with the RePEc Author Service and listed in the RePEc Genealogy. List of alumni. For a list of publications by current members of the department, see here. Register yourself.

This page is updated in the first days of each month.

---

| Journal articles |

Journal articles

2026

1. Jiang, Yawen & Dong, Zhanyu, 2026, "Differential own-price elasticity of demand for prescription drugs by clinical value," Social Science & Medicine, Elsevier, volume 390, issue C, DOI: 10.1016/j.socscimed.2025.118870.

2025

1. Bingxue Fang & Yawen Jiang, 2025, "Impacts of the diagnosis-intervention packet reform on costs and healthcare resource utilization: evidence from Guangzhou, China," Health Economics Review, Springer, volume 15, issue 1, pages 1-11, December, DOI: 10.1186/s13561-025-00615-w.
2. Yawen Jiang, 2025, "The Spillover Effects of a City‐Wide Global Budget and Case‐Based Payment Reform on Inbound Non‐Resident Patients," Health Economics, John Wiley & Sons, Ltd., volume 34, issue 9, pages 1663-1678, September, DOI: 10.1002/hec.4979.

2024

1. Yawen Jiang & Jiaxin Wen & Jiatong Sun & Yuelong Shu, 2024, "Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission–Economic Evaluation Model," PharmacoEconomics, Springer, volume 42, issue 10, pages 1111-1125, October, DOI: 10.1007/s40273-024-01412-9.

2023

1. Yawen Jiang & Shan Jiang & Limin Li & Si Shi & Mincai Li & Lei Si, 2023, "Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis," Applied Health Economics and Health Policy, Springer, volume 21, issue 3, pages 489-499, May, DOI: 10.1007/s40258-022-00784-3.

2022

1. Si Shi & Yawen Jiang, 2022, "Does supplemental private health insurance incentivize household risky financial asset investment? Evidence from the China Household Financial Survey," International Journal of Health Economics and Management, Springer, volume 22, issue 4, pages 369-421, December, DOI: 10.1007/s10754-022-09326-9.
2. Dan Cai & Si Shi & Shan Jiang & Lei Si & Jing Wu & Yawen Jiang, 2022, "Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 23, issue 4, pages 607-615, June, DOI: 10.1007/s10198-021-01384-z.
3. Weiyi Ni & Wolfgang G. Kunz & Mayank Goyal & Lijin Chen & Yawen Jiang, 2022, "Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China," Health Economics Review, Springer, volume 12, issue 1, pages 1-8, December, DOI: 10.1186/s13561-021-00352-w.

2020

1. Jiang, Yawen & Ni, Weiyi, 2020, "Impact of supplementary private health insurance on hospitalization and physical examination in China," China Economic Review, Elsevier, volume 63, issue C, DOI: 10.1016/j.chieco.2020.101514.

2019

1. Yawen Jiang & Weiyi Ni, 2019, "Risk selection into supplemental private health insurance in China," Health Economics Review, Springer, volume 9, issue 1, pages 1-11, December, DOI: 10.1186/s13561-019-0252-8.
2. Yawen Jiang & Weiyi Ni, 2019, "Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease," PharmacoEconomics, Springer, volume 37, issue 7, pages 943-952, July, DOI: 10.1007/s40273-019-00791-8.

---